Total Payments
$3,767
2024 Payments
$588.28
Companies
59
Transactions
241
Medicare Patients
2,462
Medicare Billing
$2.2M
Payment Breakdown by Category
Food & Beverage$3,755 (99.7%)
Education$11.86 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,755 | 240 | 99.7% |
| Education | $11.86 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $422.19 | 25 | $0 (2024) |
| Amgen Inc. | $223.35 | 16 | $0 (2023) |
| Lilly USA, LLC | $218.41 | 20 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $194.66 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $190.58 | 12 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $166.56 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $148.83 | 9 | $0 (2024) |
| Eisai Inc. | $147.46 | 9 | $0 (2023) |
| SOBI, INC | $123.33 | 7 | $0 (2024) |
| Incyte Corporation | $119.28 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $588.28 | 34 | Bayer Healthcare Pharmaceuticals Inc. ($133.70) |
| 2023 | $548.31 | 30 | Sirtex Medical Inc ($56.45) |
| 2022 | $539.37 | 32 | Janssen Biotech, Inc. ($58.87) |
| 2021 | $813.34 | 53 | Janssen Biotech, Inc. ($101.75) |
| 2020 | $476.96 | 30 | E.R. Squibb & Sons, L.L.C. ($83.56) |
| 2019 | $355.74 | 25 | Janssen Biotech, Inc. ($60.45) |
| 2018 | $179.34 | 14 | Lilly USA, LLC ($47.07) |
| 2017 | $265.63 | 23 | Lilly USA, LLC ($112.62) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Genentech USA, Inc. | Tecentriq (Biological), Tecentriq Hybreza | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: BioOncology | ||||||
| 11/12/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Oncology | ||||||
| 11/07/2024 | TerSera Therapeutics LLC | Xermelo (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Oncology | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: Oncology | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: BioOncology | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Oncology | ||||||
| 07/30/2024 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Hematology | ||||||
| 07/17/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/11/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Oncology | ||||||
| 05/24/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: DESMOID TUMORS | ||||||
| 05/07/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Oncology | ||||||
| 05/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Oncology | ||||||
| 04/30/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 03/18/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 479 | 7,731 | $2.0M | $380,125 |
| 2022 | 17 | 555 | 6,232 | $2.5M | $488,908 |
| 2021 | 17 | 669 | 2,721 | $2.7M | $534,971 |
| 2020 | 20 | 759 | 4,143 | $3.9M | $771,514 |
Total Patients
2,462
Total Services
20,827
Medicare Billing
$2.2M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 18 | 503 | $703,898 | $135,998 | 19.3% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 73 | 84 | $479,543 | $91,494 | 19.1% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 21 | 558 | $265,965 | $51,325 | 19.3% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 27 | 141 | $107,188 | $20,693 | 19.3% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 74 | 85 | $102,000 | $20,304 | 19.9% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 14 | 14 | $103,935 | $19,515 | 18.8% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 28 | 144 | $43,972 | $9,318 | 21.2% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 16 | 134 | $34,926 | $6,739 | 19.3% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 14 | 14 | $28,170 | $4,959 | 17.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $14,731 | $4,168 | 28.3% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 23 | 24 | $34,686 | $3,868 | 11.2% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 14 | 14 | $15,079 | $2,861 | 19.0% |
| 71270 | Ct scan of chest before and after contrast | Office | 2023 | 27 | 33 | $31,284 | $2,706 | 8.6% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 23 | 27 | $13,502 | $2,504 | 18.5% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 17 | 17 | $11,489 | $2,194 | 19.1% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 12 | 12 | $10,450 | $809.20 | 7.7% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 51 | 5,900 | $1,770 | $669.92 | 37.8% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2022 | 22 | 695 | $972,583 | $195,749 | 20.1% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 70 | 82 | $423,743 | $92,801 | 21.9% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 28 | 778 | $370,826 | $72,971 | 19.7% |
| 77301 | High precision radiation therapy planning | Office | 2022 | 21 | 21 | $155,902 | $29,641 | 19.0% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 29 | 166 | $126,193 | $24,345 | 19.3% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2022 | 75 | 88 | $105,600 | $20,842 | 19.7% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2022 | 28 | 162 | $49,468 | $10,118 | 20.5% |
| 77300 | Calculation of radiation therapy dose | Office | 2022 | 27 | 194 | $50,564 | $9,767 | 19.3% |
About Dr. Mark Harrison, MD
Dr. Mark Harrison, MD is a Radiation Oncology healthcare provider based in Mcallen, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417954124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Harrison, MD has received a total of $3,767 in payments from pharmaceutical and medical device companies, with $588.28 received in 2024. These payments were reported across 241 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($3,755).
As a Medicare-enrolled provider, Harrison has provided services to 2,462 Medicare beneficiaries, totaling 20,827 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Mcallen, TX
- Active Since 07/07/2005
- Last Updated 07/08/2007
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1417954124
Products in Payments
- OPDIVO (Biological) $172.19
- Stivarga (Drug) $165.80
- KEYTRUDA (Biological) $148.83
- Lenvima (Drug) $147.46
- CYRAMZA (Drug) $123.12
- DARZALEX (Biological) $122.85
- IMBRUVICA (Drug) $114.18
- JAKAFI (Drug) $103.28
- LONSURF (Drug) $89.09
- SIR-Spheres Microspheres (Device) $88.06
- DOPTELET (Drug) $83.34
- Doptelet (Drug) $83.09
- Neulasta (Biological) $82.33
- ZEPZELCA (Drug) $66.91
- BLENREP (Biological) $66.82
- ZYTIGA (Drug) $65.33
- Cabometyx (Drug) $64.29
- Nplate (Biological) $63.62
- Lonsurf (Drug) $63.44
- XPOVIO (Drug) $62.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.